Concurrently, analysis of clinical indicators revealed the association between abnormally low SLC26A4-AS1 expression and TNM stage, lymphatic metastasis, and distant metastasis of rectal cancer patients, implying that SLC26A4-AS1 may be involved in the process of rectal cancer. Here, SLC26A4 is linked to rectal cancer.